Literature DB >> 9684942

Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility.

S S Chatterjee1, M Nöldner, E Koch, C Erdelmeier.   

Abstract

Efforts leading to the identification of hyperforin as an antidepressive component of therapeutically used alcoholic hypericum extracts are described and discussed. Initially, the effects of this unique and major constituent of the herb were detected in peripheral organs using in vitro models and an extract was obtained by supercritical extraction of the herb by carbon dioxide. These extracts are highly enriched in hyperforin (38.8%) and are devoid of hypericines and numerous other components of alcoholic extracts. Studies with such an extract and with isolated hyperforin indicated that this acylphloroglucinol derivative can inhibit serotonin-induced responses and uptake of this neurotransmitter in peritoneal cells. Assuming that the effects of hyperforin were due to its actions on serotoninergic 5-HT3/5-HT4 receptors, further studies were conducted to investigate its effects on the CNS. These efforts revealed its antidepressant activity in the behavioral despair test and led to the working hypothesis that hyperforin and serotoninergic mechanisms are involved in the antidepressant activities of alcoholic hypericum extracts. The observations made during this study also indicate that hyperforin is the major, but not the only antidepressive component of alcoholic extracts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9684942     DOI: 10.1055/s-2007-979340

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  9 in total

1.  Selected physical and chemical properties of commercial Hypericum perforatum extracts relevant for formulated product quality and performance.

Authors:  S H Kopleman; A NguyenPho; W S Zito; F X Muller; L L Augsburger
Journal:  AAPS PharmSci       Date:  2001

Review 2.  Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

Authors:  Joanne Barnes
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

Review 3.  Drug interactions with St John's wort : mechanisms and clinical implications.

Authors:  Marcus Mannel
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Mechanism of action of St John's wort in depression : what is known?

Authors:  Veronika Butterweck
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  Hyperforin accumulates in the translucent glands of Hypericum perforatum.

Authors:  Jens Soelberg; Lise Bolt Jørgensen; Anna K Jäger
Journal:  Ann Bot       Date:  2007-04-27       Impact factor: 4.357

Review 6.  St. John's wort: role of active compounds for its mechanism of action and efficacy.

Authors:  Veronika Butterweck; Mathias Schmidt
Journal:  Wien Med Wochenschr       Date:  2007

7.  Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice.

Authors:  Rosalia Crupi; Emanuela Mazzon; Angela Marino; Giuseppina La Spada; Placido Bramanti; Fortunato Battaglia; Salvatore Cuzzocrea; Edoardo Spina
Journal:  BMC Complement Altern Med       Date:  2011-01-27       Impact factor: 3.659

8.  Phytochemical Assays of Commercial Botanical Dietary Supplements.

Authors:  Robert Krochmal; Mary Hardy; Susan Bowerman; Qing-Yi Lu; H-J Wang; Rm Elashoff; David Heber
Journal:  Evid Based Complement Alternat Med       Date:  2004-10-06       Impact factor: 2.629

9.  Herbal triplet in treatment of nervous agitation in children.

Authors:  Inga Trompetter; Bianka Krick; Gabriele Weiss
Journal:  Wien Med Wochenschr       Date:  2012-11-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.